Human Reproduction, Vol. 16, No. 10, 2103-2108,
October 2001
© 2001 European Society of Human Reproduction and Embryology
Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium
1 Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, Japan, 2 Department of Obstetrics and Gynecology, University of Helsinki, Finland, 3 Institute of Hormone Research, Jerusalem, Israel and 4 Population Council, New York, USA
BACKGROUND: The levonorgestrel-releasing intrauterine system (LNg-IUS) has been shown to be effective in the management of menorrhagia. In order to evaluate the effects of LNg-IUS on endometrial proliferation and apoptosis, proliferating cell nuclear antigen (PCNA) expression, apoptosis, Fas and Bcl-2 protein expression in the endometrium were determined at the early proliferative phase of the menstrual cycle before and 3 months after LNg-IUS insertion. METHODS: PCNA, Fas and Bcl-2 protein expression were analysed using an avidin–biotin immunoperoxidase method. Apoptosis was assessed by the terminal deoxynucleotidyl transferase-mediated deoxy-UTP nick-end labelling (TUNEL) method. RESULTS: PCNA, immunolocalized both in the nuclei of endometrial glands and stroma was less abundant 3 months after insertion (P < 0.05). Bcl-2 protein, immunolocalized in the cytoplasm of endometrial glands but not in the stroma, became scanty 3 months after insertion. Fas antigen, immunolocalized only in endometrial glands before insertion, became prominent in both endometrial glands and stroma 3 months after insertion. The apoptosis-positive rate of the nuclei in both endometrial glands and stroma was significantly higher 3 months after insertion relative to that before insertion (P < 0.05). CONCLUSIONS: LNg-IUS resulted in a decrease in endometrial proliferation and an increase in apoptosis in endometrial glands and stroma. The increase in apoptosis associated with increased Fas antigen expression and decreased Bcl-2 protein expression in the endometrium may be one of the underlying molecular mechanisms by which LNg-IUS insertion causes the atrophic change of the endometrium.
Key words: apoptosis/endometrium/levonorgestrel-releasing intrauterine system/proliferation
5 To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan. E-mail: maruo{at}kobe-u.ac.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M.K.O. Gomes, J.C. Rosa-e-Silva, S.B. Garcia, A.C. J. de Sa Rosa-e-Silva, A. Turatti, C.S. Vieira, and R.A. Ferriani Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium Hum. Reprod., November 1, 2009; 24(11): 2736 - 2745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. MOE, A. B. VEREIDE, A. ORBO, and G. SAGER High Concentrations of Progesterone and Mifepristone Mutually Reinforce Cell Cycle Retardation and Induction of Apoptosis Anticancer Res, April 1, 2009; 29(4): 1053 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-L. Alvarez Gonzalez, C. Galant, F. Frankenne, M. Nisolle, S. Labied, J.-M. Foidart, E. Marbaix, and A. Beliard Development of an animal experimental model to study the effects of levonorgestrel on the human endometrium Hum. Reprod., March 1, 2009; 24(3): 697 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Rodriguez, B.J. Rimel, W. Watkin, J. M. Turbov, C. Barry, H. Du, G. L. Maxwell, and J.M. Cline Progestin Treatment Induces Apoptosis and Modulates Transforming Growth Factor-{beta} in the Uterine Endometrium Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 578 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Stephanie, S. Labied, S. Blacher, F. Frankenne, C. Munaut, V. Fridman, A. Beliard, J.-M. Foidart, and M. Nisolle Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time Hum. Reprod., December 1, 2007; 22(12): 3084 - 3091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Fluhr, S. Krenzer, G. M. Stein, B. Stork, M. Deperschmidt, D. Wallwiener, S. Wesselborg, M. Zygmunt, and P. Licht Interferon-{gamma} and tumor necrosis factor-{alpha} sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis J. Cell Sci., December 1, 2007; 120(23): 4126 - 4133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Jain, A. Li, W. Yang, P. Minoo, and J. C. Felix Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of medroxyprogesterone acetate Hum. Reprod., March 1, 2006; 21(3): 798 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Maruo, N. Ohara, J. Wang, and H. Matsuo Sex steroidal regulation of uterine leiomyoma growth and apoptosis Hum. Reprod. Update, May 1, 2004; 10(3): 207 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yamada, S. Nakago, O. Kurachi, J. Wang, S. Takekida, H. Matsuo, and T. Maruo Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells Hum. Reprod., April 1, 2004; 19(4): 815 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.B. Lockhat, J.O. Emembolu, and J.C. Konje The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease Hum. Reprod., January 1, 2004; 19(1): 179 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.B. Laoag-Fernandez, T. Maruo, P. Pakarinen, I.M. Spitz, and E. Johansson Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis Hum. Reprod., April 1, 2003; 18(4): 694 - 699. [Abstract] [Full Text] [PDF]
|
|